Germ Cell Tumours: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 780: | Line 780: | ||
===== CSIA and IB NSGCT ===== | ===== CSIA and IB NSGCT ===== | ||
* '''Options:''' | * '''<span style="color:#ff0000">Options:</span>''' | ||
*# '''Surveillance''' | *# '''<span style="color:#ff0000">Surveillance</span>''' | ||
*# '''Adjuvant primary RPLND''' | *# '''<span style="color:#ff0000">Adjuvant primary RPLND</span>''' | ||
*# '''Adjuvant primary chemotherapy (BEPx1-2)''' | *# '''<span style="color:#ff0000">Adjuvant primary chemotherapy (BEPx1-2)</span>''' | ||
* | *#* '''Newer guidelines, such as 2019 AUA guidelines, recommend 1 cycle for CSIA and 2 cycles for CSIB''' | ||
*** '''2010 CUA Consensus Statement: BEPx2''' | *** '''2010 CUA Consensus Statement: BEPx2''' | ||
** Long-term survival approaches 100% for each | ** Long-term survival approaches 100% for each | ||